Cheung Laboratories
This article was originally published in The Gray Sheet
Executive Summary
Microwave technology manufacturer changes its name to Celsion to reflect the company's underlying purpose - to use focused heat technology to kill cancer cells. The firm recently filed an investigational device exemption with FDA to begin clinical studies of its microwave benign prostatic hyperplasia treatment system, which incorporates a microwave balloon catheter for transurethral microwave heating to shrink the prostate and compress the urethra wall. "The combination of microwave heat and balloon catheter compression creates a natural biological stent in the urethra, providing immediate relief of urinary obstruction," the company explains in an April 27 release